EGFR and nasopharyngeal carcinoma: Additionally, the prognosis of NPC patients was unaffected by EGFR, MHC-I, CD8+T, GR, TAP1, FAF2 and MHC-I/GR/TAP1/FAF2 (all P > 0.05).